West Pharmaceutical Services, Inc.

NYSE:WST 株式レポート

時価総額:US$23.9b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

West Pharmaceutical Services バランスシートの健全性

財務の健全性 基準チェック /66

West Pharmaceutical Servicesの総株主資本は$2.7B 、総負債は$206.2Mで、負債比率は7.7%となります。総資産と総負債はそれぞれ$3.6Bと$921.7Mです。 West Pharmaceutical Servicesの EBIT は$668.3Mで、利息カバレッジ比率-31.8です。現金および短期投資は$601.8Mです。

主要情報

7.7%

負債資本比率

US$206.20m

負債

インタレスト・カバレッジ・レシオ-31.8x
現金US$601.80m
エクイティUS$2.68b
負債合計US$921.70m
総資産US$3.60b

財務の健全性に関する最新情報

Recent updates

Estimating The Fair Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

May 21
Estimating The Fair Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

West Pharmaceutical: Pick And Shovels Of The Injectable Drug Industry

May 11

West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price

Mar 30
West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price

Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?

Mar 12
Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?

Why West Pharma Is Far From Done

Feb 28

West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price

Feb 20
West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price

West Pharmaceutical Services: Still Too Expensive After The Recent Drop

Feb 20

What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?

Jan 10
What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?

West Pharmaceutical: Great Business, Not So Great Valuation

Jan 08

What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You

Dec 18
What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You

West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

Nov 27
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

West Pharmaceutical Services: The Run Might Be Over

Oct 18

Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?

Sep 24
Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?

Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

Aug 22
Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

West Pharmaceutical: Revise To Buy On Exceptional Economic Characteristics

Aug 08

What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?

Jun 26
What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?

West Pharmaceutical: Hard To Justify The Price

May 26

Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

May 16
Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?

Mar 20
At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?

West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture

Feb 28
West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture

West Pharmaceutical Q4 2022 Earnings Preview

Feb 15

West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

Jan 31
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

West Pharmaceutical: An Earnings Decline Seen In 2023, Shares Still Appear Expensive

Dec 19

West Pharmaceutical declares $0.19 dividend

Dec 13

Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching

Nov 29
Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching

West Pharmaceutical Q3 2022 Earnings Preview

Oct 26

West Pharmaceutical Services (NYSE:WST) Seems To Use Debt Rather Sparingly

Oct 25
West Pharmaceutical Services (NYSE:WST) Seems To Use Debt Rather Sparingly

West Pharmaceutical Services: Shares Need To Get Cheaper To Make Sense

Oct 02

Is West Pharmaceutical Services, Inc. (NYSE:WST) Expensive For A Reason? A Look At Its Intrinsic Value

Sep 14
Is West Pharmaceutical Services, Inc. (NYSE:WST) Expensive For A Reason? A Look At Its Intrinsic Value

Is There Now An Opportunity In West Pharmaceutical Services, Inc. (NYSE:WST)?

Aug 31
Is There Now An Opportunity In West Pharmaceutical Services, Inc. (NYSE:WST)?

Do West Pharmaceutical Services' (NYSE:WST) Earnings Warrant Your Attention?

Aug 18
Do West Pharmaceutical Services' (NYSE:WST) Earnings Warrant Your Attention?

West Pharmaceutical Q2 Non-GAAP EPS, revenue beats

Jul 28

Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

Jul 27
Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

West Pharmaceutical Services: A Great Business At A Lofty Price

Jul 06

West Pharmaceutical Services, Inc. (NYSE:WST) Shares Could Be 32% Above Their Intrinsic Value Estimate

Jun 09
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Could Be 32% Above Their Intrinsic Value Estimate

財務状況分析

短期負債: WSTの 短期資産 ( $1.7B ) が 短期負債 ( $648.4M ) を超えています。

長期負債: WSTの短期資産 ( $1.7B ) が 長期負債 ( $273.3M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: WST総負債よりも多くの現金を保有しています。

負債の削減: WSTの負債対資本比率は、過去 5 年間で14.3%から7.7%に減少しました。

債務返済能力: WSTの負債は 営業キャッシュフロー によって 十分にカバー されています ( 366.9% )。

インタレストカバレッジ: WST支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。


貸借対照表


健全な企業の発掘